SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001558370-20-002906
Filing Date
2020-03-19
Accepted
2020-03-18 18:29:05
Documents
110
Period of Report
2019-12-31

Document Format Files

Seq Description Document Type Size
1 10-K osmt-20191231x10k.htm 10-K 3896755
2 EX-4.3 osmt-20191231ex439b86345.htm EX-4.3 165486
3 EX-10.35 osmt-20191231ex10351998f.htm EX-10.35 143553
4 EX-10.36 osmt-20191231ex103680d9c.htm EX-10.36 30197
5 EX-10.37 osmt-20191231ex10379f85d.htm EX-10.37 31287
6 EX-21.1 osmt-20191231ex2110163ba.htm EX-21.1 17491
7 EX-23.1 osmt-20191231ex231a00610.htm EX-23.1 7597
8 EX-23.2 osmt-20191231ex2320e0427.htm EX-23.2 3215
9 EX-31.1 osmt-20191231ex31145d621.htm EX-31.1 11199
10 EX-31.2 osmt-20191231ex312cfbe17.htm EX-31.2 11164
11 EX-32.1 osmt-20191231ex32174ac80.htm EX-32.1 8957
12 EX-32.2 osmt-20191231ex322b98716.htm EX-32.2 8831
13 GRAPHIC osmt20191231x10k001.jpg GRAPHIC 13102
14 GRAPHIC osmt20191231x10k002.jpg GRAPHIC 16760
15 GRAPHIC osmt20191231x10k003.jpg GRAPHIC 16760
  Complete submission text file 0001558370-20-002906.txt   14986913

Data Files

Seq Description Document Type Size
16 EX-101.INS osmt-20191231.xml EX-101.INS 3519356
17 EX-101.SCH osmt-20191231.xsd EX-101.SCH 72903
18 EX-101.CAL osmt-20191231_cal.xml EX-101.CAL 99885
19 EX-101.DEF osmt-20191231_def.xml EX-101.DEF 369494
20 EX-101.LAB osmt-20191231_lab.xml EX-101.LAB 735208
21 EX-101.PRE osmt-20191231_pre.xml EX-101.PRE 608180
Mailing Address 400 CROSSING BOULEVARD BRIDGEWATER NJ 08807
Business Address 400 CROSSING BOULEVARD BRIDGEWATER NJ 08807 9088091300
Osmotica Pharmaceuticals plc (Filer) CIK: 0001739426 (see all company filings)

IRS No.: 000000000
Type: 10-K | Act: 34 | File No.: 001-38709 | Film No.: 20725888
SIC: 2834 Pharmaceutical Preparations